Related Parents
Related Issuers
by Stephen Carter
Jan 28, 2026 6:01 AM ET
FIS - Fabbrica Italiana Sintetici SpA (FISITA) EUR770m (up from EUR750m) fixed/floating sr sec notes two-part. B2/B/BB- (stable/stable/stable). Via BNP (B&D)/GS jt physical books/Nomura jt glocos/Akros-BPM/Barc/BofA/BPER/Citi/IMI/JPM/KKR/MS/RBC/UniCredit jt books. No reg rights. List Lux. NY law. CoC at 101. Denoms: 100kx1k. EUR20m upsize to repay the PIK notes.
- EUR TBD fixed-rate notes due 2031 (5y). NC2 (MWC B+50bp) (50%,25%,par). Equity claw: 2y 40%. IPO claw: 2y in whole or in part at 102. Special call: 10% per year the first 2 years at 103. IPT: 6.00%-6.25%. Price talk: 5.75%-6.00%.
- EUR TBD FRN due 2031 (5y). NC1 (MWC B+50bp) (par). IPT: E+400bp at par. Price talk: E+375-400bp.
Roadshow (small group meetings) 01/26-28 (investor call at 10:30am UKT 01/26). Books close at 12pm UKT 01/28. Pricing 01/28 UK afternoon. UOP: along with EUR26m cash on hand, to refinance its existing EUR400m notes (EUR350m 5.625% sr sec notes due 08/01/27 (callable at 100) and EUR50m private placement S-L sr sec FRN due 2027), repay EUR53m cvt bond, fund EUR312m shareholder distribution (EUR20m upsize to repay the PIK notes). Equity sponsor: Bain (86%). Biz: a leading global CDMO developing and manufacturing a broad range of small molecules active pharmaceutical ingredients (APIs) for the pharmaceutical industry. HQ: Montecchio Maggiore, Vicenza, Italy.
DealRoadshow direct link: https://dealroadshow.com/e/molecule2026. Entry Code: molecule2026.